Biological activities of melanotropic peptide fatty acid conjugates.
Four fatty acids (FA, palmitic, myristic, decanoic, hexanoic) were individually conjugated to the N-terminus of the alpha-MSH fragment analog, H-Asp5-His6-D-Phe7-Arg8-Trp9-Lys10-NH2. This resulted in enhanced potency of the conjugates (compared to the unconjugated melanotropin analog) as determined in the lizard skin bioassay and in the mouse melanoma cell tyrosinase bioassay. The shorter conjugates of hexanoic and decanoic acid were at least equipotent to alpha-MSH in the lizard skin bioassay, whereas the longer myristoyl and palmitoyl analogs were 100 times less active. The myristoyl and palmitoyl conjugates exhibited a "creeping" potency in the lizard skin bioassay-that is, potency of the peptides increased with time in contact with the skins. These observations may be related to the more lipid nature of these FA-conjugates. In the tyrosinase assay, the conjugates were 10-100 times more active than alpha-MSH or the unconjugated analog. Each of the FA-melanotropic peptide conjugates exhibited prolonged (residual) melanotropic activity in both the lizard skin and melanoma cell bioassays. In other words, after removal of the melanotropin conjugates from contact with the skins or cells, responses were still manifested for hours or days thereafter. As little as 1 hr of contact with melanoma cells resulted in enhanced enzyme activity as measured 48 hr later. Since the conjugates, but not H-[Asp5, D-Phe7, Lys10]alpha-MSH5-10-NH2, exhibited prolonged activity, the conversion of reversible agonists to irreversible agonists was demonstrated.
Hadley
M E
ME
Department of Anatomy, University of Arizona, Tucson 85724.
al-Obeidi
F
F
Hruby
V J
VJ
Weinrach
J C
JC
Freedberg
D
D
Jiang
J W
JW
Stover
R S
RS
D000595:Amino Acid Sequence; D000818:Animals; D001681:Biological Assay; D002208:Caproates / Q000378:metabolism / Q000494:pharmacology; D003652:Decanoic Acids / Q000378:metabolism / Q000494:pharmacology; D005227:Fatty Acids / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D008116:Lizards; D009074:Melanocyte-Stimulating Hormones / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology*; D008544:Melanocytes / Q000187:drug effects / Q000378:metabolism; D008546:Melanoma, Experimental / Q000201:enzymology; D051379:Mice; D008969:Molecular Sequence Data; D014442:Monophenol Monooxygenase / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000138:chemical synthesis / Q000494:pharmacology*; D012867:Skin / Q000187:drug effects / Q000648:ultrastructure; D000521:alpha-MSH / Q000378:metabolism / Q000494:pharmacology*
D002208:Caproates; D003652:Decanoic Acids; D005227:Fatty Acids; D010446:Peptide Fragments; D010456:Peptides, Cyclic; C074762:MSH (5-10), cyclic; C037652:hexanoic acid; C031071:decanoic acid; D000521:alpha-MSH; D009074:Melanocyte-Stimulating Hormones; D014442:Monophenol Monooxygenase